![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: GCLC |
Gene summary for GCLC |
![]() |
Gene information | Species | Human | Gene symbol | GCLC | Gene ID | 2729 |
Gene name | glutamate-cysteine ligase catalytic subunit | |
Gene Alias | GCL | |
Cytomap | 6p12.1 | |
Gene Type | protein-coding | GO ID | GO:0000096 | UniProtAcc | E1CEI4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
2729 | GCLC | AEH-subject3 | Human | Endometrium | AEH | 7.12e-07 | 4.20e-01 | -0.2576 |
2729 | GCLC | AEH-subject5 | Human | Endometrium | AEH | 2.63e-03 | -2.05e-01 | -0.2953 |
2729 | GCLC | EEC-subject1 | Human | Endometrium | EEC | 2.29e-08 | 3.95e-01 | -0.2682 |
2729 | GCLC | EEC-subject2 | Human | Endometrium | EEC | 2.56e-02 | -1.50e-01 | -0.2607 |
2729 | GCLC | EEC-subject3 | Human | Endometrium | EEC | 6.21e-09 | -1.87e-01 | -0.2525 |
2729 | GCLC | EEC-subject4 | Human | Endometrium | EEC | 3.18e-03 | -2.29e-01 | -0.2571 |
2729 | GCLC | GSM5276934 | Human | Endometrium | EEC | 3.02e-06 | -2.58e-01 | -0.0913 |
2729 | GCLC | GSM5276935 | Human | Endometrium | EEC | 5.44e-04 | -2.66e-01 | -0.123 |
2729 | GCLC | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 8.28e-07 | -1.87e-01 | -0.1869 |
2729 | GCLC | GSM6177620_NYU_UCEC1_lib2_lib2 | Human | Endometrium | EEC | 4.34e-06 | -2.81e-01 | -0.1875 |
2729 | GCLC | GSM6177620_NYU_UCEC1_lib3_lib3 | Human | Endometrium | EEC | 5.18e-06 | -2.76e-01 | -0.1883 |
2729 | GCLC | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 8.64e-08 | -5.66e-02 | -0.1934 |
2729 | GCLC | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 2.90e-22 | -3.02e-01 | -0.1917 |
2729 | GCLC | GSM6177622_NYU_UCEC3_lib2_lib2 | Human | Endometrium | EEC | 1.68e-16 | -3.19e-01 | -0.1916 |
2729 | GCLC | GSM6177623_NYU_UCEC3_Vis | Human | Endometrium | EEC | 7.12e-05 | -2.15e-01 | -0.1269 |
2729 | GCLC | LZE2T | Human | Esophagus | ESCC | 1.47e-15 | 2.51e+00 | 0.082 |
2729 | GCLC | LZE4T | Human | Esophagus | ESCC | 7.03e-07 | 4.40e-01 | 0.0811 |
2729 | GCLC | LZE7T | Human | Esophagus | ESCC | 1.75e-10 | 9.94e-01 | 0.0667 |
2729 | GCLC | LZE24T | Human | Esophagus | ESCC | 1.59e-12 | 6.65e-01 | 0.0596 |
2729 | GCLC | LZE21T | Human | Esophagus | ESCC | 1.45e-07 | 8.55e-01 | 0.0655 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0032434113 | Thyroid | PTC | regulation of proteasomal ubiquitin-dependent protein catabolic process | 94/5968 | 134/18723 | 9.17e-20 | 1.23e-17 | 94 |
GO:1903364113 | Thyroid | PTC | positive regulation of cellular protein catabolic process | 104/5968 | 155/18723 | 1.93e-19 | 2.39e-17 | 104 |
GO:000683928 | Thyroid | PTC | mitochondrial transport | 150/5968 | 254/18723 | 2.76e-19 | 3.34e-17 | 150 |
GO:0031396113 | Thyroid | PTC | regulation of protein ubiquitination | 128/5968 | 210/18723 | 3.06e-18 | 3.27e-16 | 128 |
GO:0045862113 | Thyroid | PTC | positive regulation of proteolysis | 198/5968 | 372/18723 | 6.68e-18 | 6.91e-16 | 198 |
GO:1901800112 | Thyroid | PTC | positive regulation of proteasomal protein catabolic process | 80/5968 | 114/18723 | 4.80e-17 | 4.27e-15 | 80 |
GO:1903052112 | Thyroid | PTC | positive regulation of proteolysis involved in cellular protein catabolic process | 88/5968 | 133/18723 | 4.30e-16 | 3.39e-14 | 88 |
GO:0032436113 | Thyroid | PTC | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 66/5968 | 90/18723 | 7.51e-16 | 5.64e-14 | 66 |
GO:2000060113 | Thyroid | PTC | positive regulation of ubiquitin-dependent protein catabolic process | 73/5968 | 107/18723 | 1.19e-14 | 7.75e-13 | 73 |
GO:2001234113 | Thyroid | PTC | negative regulation of apoptotic signaling pathway | 124/5968 | 224/18723 | 2.57e-13 | 1.32e-11 | 124 |
GO:0097191113 | Thyroid | PTC | extrinsic apoptotic signaling pathway | 117/5968 | 219/18723 | 2.73e-11 | 1.03e-09 | 117 |
GO:0071496113 | Thyroid | PTC | cellular response to external stimulus | 158/5968 | 320/18723 | 4.12e-11 | 1.47e-09 | 158 |
GO:0031397113 | Thyroid | PTC | negative regulation of protein ubiquitination | 55/5968 | 83/18723 | 1.26e-10 | 4.28e-09 | 55 |
GO:0070997113 | Thyroid | PTC | neuron death | 171/5968 | 361/18723 | 4.32e-10 | 1.38e-08 | 171 |
GO:1901653111 | Thyroid | PTC | cellular response to peptide | 169/5968 | 359/18723 | 9.81e-10 | 2.89e-08 | 169 |
GO:0071214111 | Thyroid | PTC | cellular response to abiotic stimulus | 158/5968 | 331/18723 | 9.90e-10 | 2.89e-08 | 158 |
GO:0104004111 | Thyroid | PTC | cellular response to environmental stimulus | 158/5968 | 331/18723 | 9.90e-10 | 2.89e-08 | 158 |
GO:1903321113 | Thyroid | PTC | negative regulation of protein modification by small protein conjugation or removal | 59/5968 | 95/18723 | 1.26e-09 | 3.63e-08 | 59 |
GO:000700624 | Thyroid | PTC | mitochondrial membrane organization | 68/5968 | 116/18723 | 2.47e-09 | 6.88e-08 | 68 |
GO:0010639112 | Thyroid | PTC | negative regulation of organelle organization | 163/5968 | 348/18723 | 3.04e-09 | 8.39e-08 | 163 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0421625 | Endometrium | EEC | Ferroptosis | 16/1237 | 41/8465 | 1.09e-04 | 1.08e-03 | 8.08e-04 | 16 |
hsa002704 | Endometrium | EEC | Cysteine and methionine metabolism | 15/1237 | 52/8465 | 6.02e-03 | 3.12e-02 | 2.33e-02 | 15 |
hsa0421635 | Endometrium | EEC | Ferroptosis | 16/1237 | 41/8465 | 1.09e-04 | 1.08e-03 | 8.08e-04 | 16 |
hsa0027011 | Endometrium | EEC | Cysteine and methionine metabolism | 15/1237 | 52/8465 | 6.02e-03 | 3.12e-02 | 2.33e-02 | 15 |
hsa0048018 | Esophagus | ESCC | Glutathione metabolism | 44/4205 | 57/8465 | 1.81e-05 | 9.03e-05 | 4.63e-05 | 44 |
hsa0421629 | Esophagus | ESCC | Ferroptosis | 33/4205 | 41/8465 | 4.58e-05 | 1.99e-04 | 1.02e-04 | 33 |
hsa012405 | Esophagus | ESCC | Biosynthesis of cofactors | 97/4205 | 153/8465 | 3.88e-04 | 1.35e-03 | 6.94e-04 | 97 |
hsa0048019 | Esophagus | ESCC | Glutathione metabolism | 44/4205 | 57/8465 | 1.81e-05 | 9.03e-05 | 4.63e-05 | 44 |
hsa0421638 | Esophagus | ESCC | Ferroptosis | 33/4205 | 41/8465 | 4.58e-05 | 1.99e-04 | 1.02e-04 | 33 |
hsa0124012 | Esophagus | ESCC | Biosynthesis of cofactors | 97/4205 | 153/8465 | 3.88e-04 | 1.35e-03 | 6.94e-04 | 97 |
hsa042168 | Liver | NAFLD | Ferroptosis | 12/1043 | 41/8465 | 2.98e-03 | 2.96e-02 | 2.39e-02 | 12 |
hsa0421611 | Liver | NAFLD | Ferroptosis | 12/1043 | 41/8465 | 2.98e-03 | 2.96e-02 | 2.39e-02 | 12 |
hsa004809 | Liver | Cirrhotic | Glutathione metabolism | 30/2530 | 57/8465 | 2.63e-04 | 1.72e-03 | 1.06e-03 | 30 |
hsa01240 | Liver | Cirrhotic | Biosynthesis of cofactors | 66/2530 | 153/8465 | 3.11e-04 | 1.99e-03 | 1.23e-03 | 66 |
hsa0421621 | Liver | Cirrhotic | Ferroptosis | 23/2530 | 41/8465 | 4.09e-04 | 2.57e-03 | 1.58e-03 | 23 |
hsa00270 | Liver | Cirrhotic | Cysteine and methionine metabolism | 27/2530 | 52/8465 | 6.98e-04 | 4.15e-03 | 2.56e-03 | 27 |
hsa0048012 | Liver | Cirrhotic | Glutathione metabolism | 30/2530 | 57/8465 | 2.63e-04 | 1.72e-03 | 1.06e-03 | 30 |
hsa012401 | Liver | Cirrhotic | Biosynthesis of cofactors | 66/2530 | 153/8465 | 3.11e-04 | 1.99e-03 | 1.23e-03 | 66 |
hsa0421631 | Liver | Cirrhotic | Ferroptosis | 23/2530 | 41/8465 | 4.09e-04 | 2.57e-03 | 1.58e-03 | 23 |
hsa002701 | Liver | Cirrhotic | Cysteine and methionine metabolism | 27/2530 | 52/8465 | 6.98e-04 | 4.15e-03 | 2.56e-03 | 27 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
GCLC | SNV | Missense_Mutation | c.832G>C | p.Ala278Pro | p.A278P | P48506 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-A7-A13D-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD | |
GCLC | SNV | Missense_Mutation | c.1018N>C | p.Gly340Arg | p.G340R | P48506 | protein_coding | tolerated(1) | probably_damaging(0.959) | TCGA-BH-A18V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
GCLC | SNV | Missense_Mutation | novel | c.1180N>C | p.Glu394Gln | p.E394Q | P48506 | protein_coding | tolerated(0.18) | possibly_damaging(0.502) | TCGA-LL-A73Y-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | taxotere | SD |
GCLC | insertion | In_Frame_Ins | novel | c.1398_1399insATC | p.Val466_Asp467insIle | p.V466_D467insI | P48506 | protein_coding | TCGA-AN-A04C-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
GCLC | insertion | Nonsense_Mutation | novel | c.1396_1397insCATCTTAGATGATGAAATGGCATCTGGATTGCTTAC | p.Val466delinsAlaSerTerMetMetLysTrpHisLeuAspCysLeuLeu | p.V466delinsAS*MMKWHLDCLL | P48506 | protein_coding | TCGA-AN-A04C-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
GCLC | SNV | Missense_Mutation | novel | c.737G>A | p.Gly246Asp | p.G246D | P48506 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
GCLC | SNV | Missense_Mutation | novel | c.1037T>C | p.Ile346Thr | p.I346T | P48506 | protein_coding | tolerated(0.34) | probably_damaging(0.94) | TCGA-5M-AAT6-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
GCLC | SNV | Missense_Mutation | novel | c.755N>C | p.Val252Ala | p.V252A | P48506 | protein_coding | deleterious(0) | benign(0.231) | TCGA-AA-3877-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
GCLC | SNV | Missense_Mutation | novel | c.1787N>C | p.Glu596Ala | p.E596A | P48506 | protein_coding | tolerated(0.15) | benign(0.003) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GCLC | SNV | Missense_Mutation | c.784N>A | p.Ala262Thr | p.A262T | P48506 | protein_coding | deleterious(0) | benign(0.228) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
2729 | GCLC | DRUGGABLE GENOME, ENZYME | BSO | 9660546 | ||
2729 | GCLC | DRUGGABLE GENOME, ENZYME | BUTHIONINE SULPHOXIMINE | 11705692 | ||
2729 | GCLC | DRUGGABLE GENOME, ENZYME | CISPLATIN | CISPLATIN | 9660546 | |
2729 | GCLC | DRUGGABLE GENOME, ENZYME | ETHANOL | ALCOHOL | 10385658 | |
2729 | GCLC | DRUGGABLE GENOME, ENZYME | sulfamethoxazole | SULFAMETHOXAZOLE | 22824134 | |
2729 | GCLC | DRUGGABLE GENOME, ENZYME | ANTIOXIDANT | 15485876 | ||
2729 | GCLC | DRUGGABLE GENOME, ENZYME | CBDCA | CARBOPLATIN | 11911273 | |
2729 | GCLC | DRUGGABLE GENOME, ENZYME | BUTHIONINE SULFOXIMINE | 8101766,9610371 | ||
2729 | GCLC | DRUGGABLE GENOME, ENZYME | L-BUTHIONINE SULFOXIMINE | 9660546 |
Page: 1 |